Showing results (1701-1710 of 1,712) with videos related to

Sort By:
Pageof 172
Frontiers in Public Health|September 3, 2024
Multi-dimensional epidemiology and informatics data on COVID-19 wave at the end of zero COVID policy in ChinaXin-Sheng Yu, Shaoying Tan, Wanting Tang, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|August 2, 2023
[Risk factors for neonatal asphyxia and establishment of a nomogram model for predicting neonatal asphyxia in Hubei Enshi Tujia and Miao Autonomous Prefecture: a multicenter study]Fang Jin, Yu Chen, Yi-Xun Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2015
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activationDong-Sheng Huang, Zhaohui Wang, Xu-Jun He, et al.
Msphere|February 2, 2022
Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive ModelKuan-Ting Liu, Yu-Nong Gong, Chung-Guei Huang, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
Cancer Medicine|September 20, 2022
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II studyGuo-Ming Shi, Xiao-Yong Huang, Tian-Fu Wen, et al.
Biosensors & Bioelectronics|April 15, 2021
Development of flexible electrochemical impedance spectroscopy-based biosensing platform for rapid screening of SARS-CoV-2 inhibitorsLik-Voon Kiew, Chia-Yu Chang, Sheng-Yu Huang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 20, 2024
Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort studyZhiyong Guo, Yao Liu, Qi Ling, et al.
Nature Medicine|March 5, 2021
Transcriptional mediators of treatment resistance in lethal prostate cancerMeng Xiao He, Michael S Cuoco, Jett Crowdis, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Pageof 172